Transcriptome profiling revealed that HRH2 and CREB5 expression were increased in viral hepatitis and NASH, confirming involvement of the pathway in disease progression across the major etiologies (Fig. 7a, b). This evidence concerns the gene CREB5 and metabolic dysfunction-associated steatohepatitis.